MAPP BIOPHARMACEUTICAL, INC.

Organization

SAN DIEGO, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-respiratory syncytial virus antibodies, methods of their gener...
- Patent number 11,725,045
- Issue date Aug 15, 2023
- MAPP BIOPHARMACEUTICAL, INC.
- Laura M. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of Ebola infections
- Patent number 11,407,816
- Issue date Aug 9, 2022
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of Ebola infections
- Patent number 11,407,817
- Issue date Aug 9, 2022
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of Ebola infections
- Patent number 11,254,732
- Issue date Feb 22, 2022
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of Ebola infections
- Patent number 11,242,378
- Issue date Feb 8, 2022
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of Ebola infections
- Patent number 11,242,379
- Issue date Feb 8, 2022
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies and cocktails for treatment of ebola infections
- Patent number 10,836,810
- Issue date Nov 17, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, METHODS OF THEIR GENER...
- Publication number 20240228597
- Publication date Jul 11, 2024
- MAPP BIOPHARMACEUTICAL, INC.
- Laura M. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20230044044
- Publication date Feb 9, 2023
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS...
- Publication number 20230000979
- Publication date Jan 5, 2023
- Albert Einstein College of Medicine
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS...
- Publication number 20210355195
- Publication date Nov 18, 2021
- Albert Einstein College of Medicine
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20200354437
- Publication date Nov 12, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20200354438
- Publication date Nov 12, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20200299362
- Publication date Sep 24, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20200299361
- Publication date Sep 24, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20200299363
- Publication date Sep 24, 2020
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20190263894
- Publication date Aug 29, 2019
- MAPP BIOPHARMACEUTICAL, INC.
- Andrew Hiatt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20190247501
- Publication date Aug 15, 2019
- MAPP BIOPHARMACEUTICAL, INC.
- Andrew Hiatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
- Publication number 20180244758
- Publication date Aug 30, 2018
- MAPP BIOPHARMACEUTICAL, INC.
- Zachary A. Bornholdt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyR...
- Publication number 20130149300
- Publication date Jun 13, 2013
- ICON GENETICS GMBH
- Andrew Hiatt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 30

Research Projects

Information Research Project
Development of highly potent human monoclonal for RSV immuno-prophy...
- Application id 10208698
- Award notice date Jul 8, 2021
Information Research Project
Development of highly potent human monoclonal for RSV immuno-prophy...
- Application id 10080251
- Award notice date Jul 2, 2020
Information Research Project
Post-exposure immunotherapy for ricin exposure
- Application id 10053943
- Award notice date Apr 6, 2020
Information Research Project
MR191_ An Immunoprotectant for Marburg Virus
- Application id 9732410
- Award notice date Jun 12, 2019
Information Research Project
Development of highly potent human monoclonals for RSV immunoprophy...
- Application id 9621366
- Award notice date Dec 28, 2018
Information Research Project
Post-exposure immunotherapy for ricin exposure
- Application id 9620817
- Award notice date Jun 29, 2018
Information Research Project
MR191_ An Immunoprotectant for Marburg Virus
- Application id 9478966
- Award notice date Jun 26, 2018
Information Research Project
Direct Sequencing of Antibodies of the Influenza Immune Response
- Application id 9692298
- Award notice date Apr 23, 2018
Information Research Project
An Immunoprotectant for Argentine Hemorrhagic Fever
- Application id 9460755
- Award notice date Mar 15, 2018
Information Research Project
Direct Sequencing of Antibodies of the Influenza Immune Response
- Application id 9664237
- Award notice date Mar 2, 2018
Information Research Project
Development of highly potent human monoclonals for RSV immunoprophy...
- Application id 9466592
- Award notice date Jan 5, 2018
Information Research Project
Direct Sequencing of Antibodies of the Influenza Immune Response
- Application id 9409463
- Award notice date Aug 28, 2017
Information Research Project
MR191_ An Immunoprotectant for Marburg Virus
- Application id 9346407
- Award notice date May 1, 2017
Information Research Project
An Immunoprotectant for Argentine Hemorrhagic Fever
- Application id 9246419
- Award notice date Mar 24, 2017
Information Research Project
Direct sequencing of serum antibodies after infection
- Application id 9253986
- Award notice date Jan 17, 2017
Information Research Project
Rapid Response Agents Against Filovirus Outbreaks Using Vectored Im...
- Application id 9200868
- Award notice date Aug 1, 2016
Information Research Project
An SEB Immunoprotectant
- Application id 9110186
- Award notice date Jul 28, 2016
Information Research Project
An Immunoprotectant for Marburg Virus
- Application id 9098445
- Award notice date Jun 13, 2016
Information Research Project
An Antibody Immunoprotectant for Category B Toxins
- Application id 9067312
- Award notice date May 26, 2016
Information Research Project
An Immunoprotectant for Argentine Hemorrhagic Fever
- Application id 9029292
- Award notice date Mar 18, 2016
Information Research Project
An SEB Immunoprotectant
- Application id 8915032
- Award notice date Jul 14, 2015
Information Research Project
An Immunoprotectant for Marburg Virus
- Application id 8874839
- Award notice date Jun 24, 2015
Information Research Project
A human monoclonal for RSV prophylaxis
- Application id 8876581
- Award notice date Jun 18, 2015
Information Research Project
An Antibody Immunoprotectant for Category B Toxins
- Application id 8848027
- Award notice date May 13, 2015
Information Research Project
An Immunoprotectant for Argentine Hemorrhagic Fever
- Application id 8840490
- Award notice date Mar 5, 2015
Information Research Project
Pseudomonas antibodies with designed glycans
- Application id 8833215
- Award notice date Jan 5, 2015
Information Research Project
Novel Immunotherapy for Brain Cancer
- Application id 8833722
- Award notice date Sep 25, 2014
Information Research Project
An SEB Immunoprotectant
- Application id 8711005
- Award notice date Aug 20, 2014
Information Research Project
A human monoclonal for RSV prophylaxis
- Application id 8781499
- Award notice date Jun 20, 2014
Information Research Project
An Immunoprotectant for Marburg Virus
- Application id 8781884
- Award notice date Jun 18, 2014

MAPP BIOPHARMACEUTICAL, INC.

Organization

Patents Grantslast 30 patents

Anti-respiratory syncytial virus antibodies, methods of their gener...

Monoclonal antibodies and cocktails for treatment of Ebola infections

Monoclonal antibodies and cocktails for treatment of Ebola infections

Monoclonal antibodies and cocktails for treatment of Ebola infections

Monoclonal antibodies and cocktails for treatment of Ebola infections

Monoclonal antibodies and cocktails for treatment of Ebola infections

Monoclonal antibodies and cocktails for treatment of ebola infections

Patents Applicationslast 30 patents

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, METHODS OF THEIR GENER...

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS...

ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS...

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS

MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyR...

NIH Research Projectlast 12 months

Research Projects

Development of highly potent human monoclonal for RSV immuno-prophy...

Development of highly potent human monoclonal for RSV immuno-prophy...

Post-exposure immunotherapy for ricin exposure

MR191_ An Immunoprotectant for Marburg Virus

Development of highly potent human monoclonals for RSV immunoprophy...

Post-exposure immunotherapy for ricin exposure

MR191_ An Immunoprotectant for Marburg Virus

Direct Sequencing of Antibodies of the Influenza Immune Response

An Immunoprotectant for Argentine Hemorrhagic Fever

Direct Sequencing of Antibodies of the Influenza Immune Response

Development of highly potent human monoclonals for RSV immunoprophy...

Direct Sequencing of Antibodies of the Influenza Immune Response

MR191_ An Immunoprotectant for Marburg Virus

An Immunoprotectant for Argentine Hemorrhagic Fever

Direct sequencing of serum antibodies after infection

Rapid Response Agents Against Filovirus Outbreaks Using Vectored Im...

An SEB Immunoprotectant

An Immunoprotectant for Marburg Virus

An Antibody Immunoprotectant for Category B Toxins

An Immunoprotectant for Argentine Hemorrhagic Fever

An SEB Immunoprotectant

An Immunoprotectant for Marburg Virus

A human monoclonal for RSV prophylaxis

An Antibody Immunoprotectant for Category B Toxins

An Immunoprotectant for Argentine Hemorrhagic Fever

Pseudomonas antibodies with designed glycans

Novel Immunotherapy for Brain Cancer

An SEB Immunoprotectant

A human monoclonal for RSV prophylaxis

An Immunoprotectant for Marburg Virus